HUTCHMED (China) Limited, together with its subsidiaries, discovers, develops, and commercializes targeted therapeutics and immunotherapies to treat cancer and immunological diseases in Hong Kong, the United States, and internationally. It ...
Leadership
Chig Fung Cheng BEc, CA
Acting CEO, CFO & Executive Director
Wei-Guo Su B.Sc., Ph.D.
CEO, Chief Scientific Officer & Executive Director (Leave of Absence)
Yiling Cui
Executive VP & Head of Operations
Xinhui Hu Ph.D.
Executive Vice President & Chief Technical Officer
David Ng
Head of Investor Relations & Capital Strategies
Charles George Rupert Nixon
Group General Counsel
Kin Hung Lee M.B.A.
Senior Vice President of Corporate Management & Communications
Selina Zhang
Senior Vice President of Global Human Resources
Qingmei Wang Ph.D.
Executive Vice President of Business Development & Strategic Alliances
